Corporate Support
Sitemap
Singapore

ShareInvestor.com

Mobile Edition
Mode - Streaming
Switch to Static Mode?

Price Highlight

Index Highlight

Chart
STI
2,707.2
6.8 (0.25%)

 

  • STI Straits Times Index
    2,707.2
    6.8 (0.25%)
     
  • KLCI FTSE Bursa Malaysia KLCI
    1,561.8
    23.3 (1.52%)
    Index delayed 15 minutes
  • HSI Hang Seng Index
    24,366.3
    40.7 (0.17%)
    Index delayed 15 minutes
  • SSE SSE Composite Index
    2,919.3
    -4.1 (-0.14%)
    Index delayed 15 minutes
  • N225 Nikkei 225
    22,695.7
    82.0 (0.36%)
    Index delayed 20 minutes
  • JCI Jakarta Composite Index
    4,916.7
    -24.3 (-0.49%)
    Index delayed 10 minutes

SGX Market

Bursa Market

HKEx Market

SET Market

IDX Market

ASX Market

NYSE Market

NASDAQ Market

NYSE American Market

  • Volume: 1,438.7M
  • Value: 2,166.9M
  • Rise: 155
  • Fall: 187
  • Unch: 468

Intraday Market Ticker Help

Intraday Market Ticker
Time Name Type Price Vol
  • Top Active

  • Top Gainer

  • Top Loser

Top Counters
Name Last Change
Rex Intl0.187-0.005
ComfortDelGro1.570-0.040
Singtel2.580+0.010
ESR-REIT0.410+0.015
SPH1.370+0.010
NetLink NBN Tr1.020+0.035
3Cnergy0.024+0.001
CapitaMall Trust2.090-0.050
Mapletree Log Tr1.940-0.010
YZJ Shipbldg SGD1.010-0.010

World Indices

World Indices
Name Last Change
Nasdaq 9,682.9 +74.5
HSI 24,366.3 +40.7
HSCEI 9,967.9 +0.4
Jakarta 4,916.7 -24.3
Nikkei 225 22,695.7 +82.0
SSE Comp 2,919.3 -4.1
Shanghai A 3,060.0 -4.3
Shanghai B 205.7 +0.4
KOSPI 2,151.2 +4.2

Asian Indices delayed. US Indices updated twice daily at 7:30am and 7:30pm.

Fundamental - Factsheet

Help
  • Factsheet

  • Print

INDIA GLOBALIZATION CAPITAL INC INDIA GLOBALIZATION CAPITAL
Updated on 03 Jun 2020 (End of trading day)
Last (USD): 0.560 Change: - High: 0.577 Remarks: -
Change (%): +0.05 Low: 0.560
Open 0.569 Yesterday's Close 0.56
Buy Price - Sell Price -
Buy Volume (share) - Sell Volume (share) -
Cumulative Volume (share) 339,324 Cumulative Value
Click to show Stock Prices chart

Key Statistics

EPS (USD) a -0.13401 Trailing EPS (USD) e -0.18772 NAV (USD) b 0.9743
PE a - Trailing PE f - Price / NAV b 0.5751
Dividend (USD) d - Cash In Hand (USD) g 0.3313 Issued & Paid-up Shares c 39,320,000
Dividend Yield (%) d - Price / Cash In Hand g 1.691 Treasury Shares h -
Beta - 75 Daysi - R-Squared - 75 Days(%)i - Market Cap (M) 17.129
Beta - 500 Daysi - R-Squared - 500 Days (%)i - Enterprise Value (M) 1.987
Piotroski F Score 3 Exchange Code IGC Par Value ( $ ) n.a.
52 Weeks Volatility (%) 95.18 Free Float (%) 85.7
Sector & Industry Health Technology - Biotechnology
Notes:
  1. Based on latest Full Year results announcement, adjusted for the current number of shares.
  2. Based on latest results announcement (Full Year, Half Year or Interim), adjusted for carrying value of "Other Share Capital", illustrative financial effects of corporate actions (if applicable) and the current number of shares.
  3. Rounded to the nearest thousand. Updated on 11 Feb 2020.Please click here for more information.
  4. Dividend is based on latest Full Year results announcement, adjusted for current number of shares and excludes special dividend.
  5. Summation of the earnings from the latest 4 Quarter (or 2 Half Year) results announcement, adjusted for the current number of shares.
  6. Based on Trailing EPS.
  7. Based on reported cash and cash equivalents at end and extracted from the latest results announcement (Full Year, Half Year or Interim), adjusted for the current number of shares.
  8. Rounded to the nearest thousand. Updated on 29 Jul 2015.
  9. Beta and R-Squared are calculated in relation to the market index using the historical daily closing values of the stock and index as data points.

Peer Comparison

Type Name Market Market Cap (M)a PE b Trailing PE c Price / NAV d Dividend Yield (%)d
Reference INDIA GLOBALIZATION CAPITAL INC NYSE American 17.129 - - 0.5751 -
Industry Biotechnology NYSE American 115.694 - - 3.4503 -
Local Peer NANOVIRICIDES INC NYSE American 450.965 - - 58.4150 -
Local Peer CAN FITE BIOPHARMA LTD SPON ADS EA REP 30 ORD SHS(POST REV SPL NYSE American 300.066 - - 340.0000 -
Local Peer PFENEX INC NYSE American 172.232 162.775 - 2.0707 -
Local Peer IBIO INC NYSE American 144.798 - - 36.5340 -
Local Peer LINEAGE CELL THERAPEUTICS INC NYSE American 136.337 - - 1.2802 -
Local Peer CEL-SCI CORP NYSE American 129.490 - - 10.6064 -
Local Peer MATINAS BIOPHARMA HOLDINGS INC NYSE American 78.967 - - 1.0723 -
Local Peer AIM IMMUNOTECH INC NYSE American 73.550 - - 2.1418 -
Local Peer PALATIN TECHNOLOGIES INC NYSE American 86.501 2.418 2.332 0.9979 -
Local Peer 22ND CENTURY GROUP INC NYSE American 81.591 - - 1.3994 -
Local Peer ARMATA PHARMACEUTICALS INC NYSE American 68.799 - - 2.0548 -
Local Peer SYNTHETIC BIOLOGICS INC NYSE American 52.581 - - -10.0737 -
Other Local Peers ORAGENICS INC (NYSE American), ACTINIUM PHARMACEUTICALS INC (NYSE American), NOVABAY PHARMACEUTICALS INC (NYSE American)
Global Peer AMGEN INC NASDAQ 130,002.587 16.578 16.938 13.7061 2.639
Global Peer GILEAD SCIENCES INC NASDAQ 93,297.600 17.322 18.802 4.2279 3.420
Global Peer CSL ASX 133,594.837 49.795 46.118 15.4473 0.901
Global Peer AMGEN-T HKEx 588,247.000 9.574 9.804 8.0015 4.569
Global Peer VERTEX PHARMACEUTICAL NASDAQ 71,822.322 61.031 47.535 11.1152 -
Global Peer REGENERON PHARMACEUTICALS INC NASDAQ 67,994.776 32.137 29.831 5.6041 -
Global Peer ILLUMINA INC NASDAQ 52,673.040 52.568 55.916 11.3642 -
Global Peer BIOGEN INC NASDAQ 49,380.386 8.386 8.400 3.9357 -
Global Peer AGILENT TECHNOLOGIES INC NYSE 27,941.231 26.089 40.910 5.8601 0.726
Global Peer SEATTLE GENETICS INC NASDAQ 26,839.465 - - 15.2011 -
Other Global Peers ALEXION PHARMACEUTICAL INC (NASDAQ), MODERNA INC (NASDAQ), INCYTE CORPORATION (NASDAQ), WUXI BIO (HKEx), SINO BIOPHARM (HKEx), BIOMARIN PHARMACEUTICAL (NASDAQ), ALNYLAM PHARMACEUTICALS INC (NASDAQ), BEIGENE (HKEx), GALAPAGOS NV SPON ADR REPR 1 ORD SHS (NASDAQ), BEIGENE LTD SPON ADS EACH REPR 13 ORD SHS (NASDAQ), EXACT SCIENCES CORP (NASDAQ), BIONTECH SE SPON ADS EACH REP 1 ORD SHS (NASDAQ), SAREPTA THERAPEUTICS INC (NASDAQ), NEUROCRINE BIOSCIENCES INC (NASDAQ), BIO-TECHNE CORP (NASDAQ), 10X GENOMICS INC (NASDAQ), IONIS PHARMACEUTICALS INC (NASDAQ), IMMUNOMEDICS INC (NASDAQ), ACADIA PHARMACEUTICALS INC (NASDAQ), EXELIXIS INC (NASDAQ), ASCENDIS PHARMA A/S SPON ADR EACH REP 1 ORD SHS (NASDAQ), ALLOGENE THERAPEUTICS INC (NASDAQ), ZAI LAB LIMITED ADS EACH REP 1 ORD SHS (NASDAQ), ACCELERON PHARMA (NASDAQ), IOVANCE BIOTHERAPEUTICS INC (NASDAQ), EMERGENT BIOSOLUTIONS INC (NYSE), GENSCRIPT BIO (HKEx), MORPHOSYS SPON ADS EACH REP 0.25 ORD SHS (NASDAQ), MIRATI THERAPEUTICS INC (NASDAQ), CHINA BIOLOGIC PRODUCTS HLDGS INC (NASDAQ), Lonza (SGX), GLOBAL BLOOD THERAPEUTICS INC (NASDAQ), BLUEBIRD BIO INC (NASDAQ), VIR BIOTECHNOLOGY INC (NASDAQ), ULTRAGENYX PHARMACEUTICAL INC (NASDAQ), CRISPR THERAPEUTICS AG (NASDAQ), CHEMOCENTRYX INC (NASDAQ), MOMENTA PHARMACEUTICALS INC (NASDAQ), BLUEPRINT MEDICINES CORP (NASDAQ), AGIOS PHARMACEUTICALS INC (NASDAQ), DECIPHERA PHARMACEUTICALS INC (NASDAQ), ARROWHEAD PHARMACEUTICALS INC (NASDAQ), HALOZYME THERAPEUTICS INC (NASDAQ), ARENA PHARMACEUTICALS INC (NASDAQ), AMICUS THERAPEUTICS INC (NASDAQ), 3SBIO (HKEx), PTC THERAPEUTICS INC (NASDAQ), NOVAVAX INC (NASDAQ), FIBROGEN INC (NASDAQ), DENALI THERAPEUTICS INC (NASDAQ), KODIAK SCIENCES INC (NASDAQ), UNIQURE N.V. (NASDAQ), ALKERMES PLC (NASDAQ), VIELA BIO INC (NASDAQ), ALECTOR INC (NASDAQ), INSMED INC (NASDAQ), FATE THERAPEUTICS (NASDAQ), BENITEC BIOPHARMA INC (NASDAQ), ALPHAMAB-B (HKEx), TG THERAPEUTICS INC (NASDAQ), ARCUS BIOSCIENCES INC (NYSE), EIDOS THERAPEUTICS INC (NASDAQ), AURINIA PHARMACEUTICALS INC (NASDAQ), ZENTALIS PHARMACEUTICALS INC (NASDAQ), XENCOR INC (NASDAQ), EPIZYME INC (NASDAQ), ADVERUM BIOTECHNOLOGIES INC (NASDAQ), HERON THERAPEUTICS INC (NASDAQ), SANGAMO THERAPEUTICS INC (NASDAQ), LIGAND PHARMACEUTICAL INC (NASDAQ), TWIST BIOSCIENCE CORPORATION (NASDAQ), AKEBIA THERAPEUTICS INC (NASDAQ), MESOBLAST LTD SPON ADR EACH REP 5 SHS (NASDAQ), DICERNA PHARMACEUTICALS INC. (NASDAQ), MESOBLAST LTD (ASX), MYOVANT SCIENCES LTD (NYSE), ADAPTIMMUNE THERAPEUTICS PLC ADS EACH REPR 6 SHS (SPONS) (NASDAQ), EDITAS MEDICINE INC (NASDAQ), VIVA BIOTECH (HKEx), LUMINEX CORP(DEL) (NASDAQ), BLACK DIAMOND THERAPEUTICS INC (NASDAQ), MERSANA THERAPEUTICS INC (NASDAQ), INTRA-CELLUAR THERAPIES INC (NASDAQ), REGENXBIO INC (NASDAQ), BEAM THERAPEUTICS INC (NASDAQ), NGM BIOPHARMACEUTICALS INC (NASDAQ), COHERUS BIOSCIENCES INC (NASDAQ), CORTEXYME INC (NASDAQ), ARVINAS INC (NASDAQ), VERACYTE INC (NASDAQ), KARYOPHARM THERAPEUTICS INC (NASDAQ), CYTOKINETICS INC (NASDAQ), TRANSLATE BIO INC (NASDAQ), COMPUGEN (NASDAQ), HAOHAI BIOTEC (HKEx), POLYNOVO LIMITED (ASX), NANOSTRING TECHNOLOGIES INC (NASDAQ), ESPERION THERAPEUTICS INC (NASDAQ), MYRIAD GENETICS INC (NASDAQ), FRONTAGE (HKEx), INTELLIA THERAPEUTICS INC (NASDAQ), AIMMUNE THERAPEUTICS INC (NASDAQ), MACROGENICS INC (NASDAQ), ENANTA PHARMACEUTICALS INC (NASDAQ), SORRENTO THERAPEUTICS INC (NASDAQ), ROCKET PHARMACEUTICALS INC (NASDAQ), PASSAGE BIO INC (NASDAQ), BIOXCEL THERAPEUTICS INC (NASDAQ), KURA ONCOLOGY INC (NASDAQ), RHYTHM PHARMACEUTICALS INC (NASDAQ), IMMUNOGEN INC (NASDAQ), DYNAVAX TECHNOLOGIES CORP (NASDAQ), STOKE THERAPEUTICS INC (NASDAQ), CUE BIOPHARMA INC (NASDAQ), NEXTCURE INC (NASDAQ), OMEROS CORP (NASDAQ), ASCENTAGE-B (HKEx), KINTOR PHARMA-B (HKEx), CELLECTIS ADS EACH REPR 1 ORD SPON (NASDAQ), ATARA BIOTHERAPEUTICS INC (NASDAQ), AVROBIO INC (NASDAQ), NANTKWEST INC (NASDAQ), CARA THERAPEUTICS INC (NASDAQ), KADMON HLDGS INC (NYSE), REPLIMUNE GROUP INC (NASDAQ), AGENUS INC (NASDAQ), MOLECULAR TEMPLATES INC (NASDAQ), AVITA MEDICAL LTD SPON ADS EACH REP 20 ORD SHS (NASDAQ), AVITA MEDICAL LTD (ASX), RETROPHIN INC (NASDAQ), HOMOLOGY MEDICINES INC (NASDAQ), MERIDIAN BIOSCIENCE INC COM (NASDAQ), TRILLIUM THERAPEUTICS INC (NASDAQ), VANDA PHARMACE INC (NASDAQ), ZIOPHARM ONCOLOGY INC (NASDAQ), BELLUS HEALTH INC (NASDAQ), ARDELYX INC (NASDAQ), CLOVIS ONCOLOGY INC (NASDAQ), AUTOLUS THERAPEUTICS PLC SPON ADS EA REP 1 ORD SHS (NASDAQ), STEMLINE THERAPEUTICS INC (NASDAQ), RADIUS HEALTH INC (NASDAQ), MORPHIC HOLDING INC (NASDAQ), ATHERSYS INC (NASDAQ), SYNDAX PHARMACEUTICALS INC (NASDAQ), APTOSE BIOSCIENCES INC (NASDAQ), PREVAIL THERAPEUTICS INC (NASDAQ), PROTAGONIST THERAPEUTICS INC (NASDAQ), PACIFIC BIOSCIENCES CALIFORNIA INC (NASDAQ), FREQUENCY THERAPEUTICS INC (NASDAQ), FLEXION THERAPEUTICS INC (NASDAQ), MEIRAGTX HOLDINGS PLC (NASDAQ), DBV TECHNOLOGIES SPON ADR EACH REPR 0.5 ORD (NASDAQ), CORBUS PHARMACEUTICALS HOLDINGS IN (NASDAQ), ANAPTYSBIO INC (NASDAQ), VIKING THERAPEUTICS INC (NASDAQ), NEOLEUKIN THERAPEUTICS INC (NASDAQ), RUBIUS THERAPEUTICS INC (NASDAQ), SCHOLAR ROCK HOLDING CORPORATION (NASDAQ), UROGEN PHARMA LTD (NASDAQ), SINOMAB BIO-B (HKEx), GERON CORP (NASDAQ), INNATE PHARMA SPON ADS EACH REP 1 ORD SHS (NASDAQ), CO DIAGNOSTICS INC (NASDAQ), RAPT THERAPEUTICS INC (NASDAQ), UNITY BIOTECHNOLOGY INC (NASDAQ), SINOVAC BIOTECH LTD (NASDAQ), VBI VACCINES INC CDA (NASDAQ), XENON PHARMACEUTICALS INC (NASDAQ), HARPOON THERAPEUTICS INC (NASDAQ), VOYAGER THERAPEUTICS INC (NASDAQ), PROTHENA CORP PLC (NASDAQ), SYROS PHARMACEUTICALS INC (NASDAQ), ASCLETIS-B (HKEx), PUMA BIOTECHNOLOGY INC (NASDAQ), PERSONALIS INC (NASDAQ), CALITHERA BIOSCIENCES INC (NASDAQ), XBIOTECH INC (NASDAQ), VERMILLION INC (NASDAQ), MERUS B V (NASDAQ), PDL BIOPHARMA INC (NASDAQ), SERES THERAPEUTICS (NASDAQ), MAGENTA THERAPEUTICS INC (NASDAQ), PRECISION BIOSCIENCES INC (NASDAQ), CYTOMX THERAPEUTICS INC (NASDAQ), PRECIGEN INC (NASDAQ), PROGENICS PHARMACEUTICALS INC (NASDAQ), ESSEX BIO-TECH (HKEx), WAVE LIFE SCIENCES LTD (NASDAQ), SPECTRUM PHARMACEUTICALS INC (NASDAQ), AVID BIOSERVICES INC (NASDAQ), SELECTA BIOSCIENCES INC (NASDAQ), KAMADA (NASDAQ), RIGEL PHARMACEUTICALS INC (NASDAQ), VERASTEM INC (NASDAQ), BICYCLE THERAPEUTICS PLC SPON ADS EACH REP 1 ORD SHS (NASDAQ), MANNKIND CORPORATION (NASDAQ), LEE'S PHARM (HKEx), EIGER BIOPHARMACEUTICALS INC (NASDAQ), CONCERT PHARMACEUTICALS INC (NASDAQ), NEPTUNE WELLNESS SOLUTIONS INC (NASDAQ), PROQR THERAPEUTICS N V (NASDAQ), ADURO BIOTECH INC (NASDAQ), CASI PHARMACEUTICALS INC (NASDAQ), DPHARMA (Bursa), CHIASMA INC (NASDAQ), ADMA BIOLOGICS INC (NASDAQ), CYMABAY THERAPEUTICS INC (NASDAQ), CELLULAR BIOMEDICINE GROUP INC (NASDAQ), BBI LIFE SCI (HKEx), EVOFEM BIOSCIENCES INC (NASDAQ), SUMMIT THERAPEUTICS PLC ADS EACH REPR 5 ORD (NASDAQ), AFFIMED N V (NASDAQ), FORTRESS BIOTECH INC (NASDAQ), LIMINAL BIOSCIENCES INC (NASDAQ), MEDICINOVA INC (NASDAQ), TELIX PHARMACEUTIC (ASX), ANAVEX LIFE SCIENCES CORPORATION (NASDAQ), INFLARX N V (NASDAQ), NEUROBO PHARMACEUTICALS INC (NASDAQ), BRAINSTROM CELL THERAPEUTICS (NASDAQ), XOMA CORP (NASDAQ), TIZIANA LIFE SCIENCES PLC SPON ADS EACH REPR 10 ORD SHS (NASDAQ), AXCELLA HEALTH INC (NASDAQ), GENFIT SPON ADS EACH REP 1 ORD SHS (NASDAQ), NUCANA PLC SPON ADR EACH REP 1 ORD SHS (NASDAQ), VAXART INC (NASDAQ), LEXICON PHARMACEUTICALS INC (NASDAQ), ARAVIVE INC (NASDAQ), IVERIC BIO INC (NASDAQ), CHIMERIX INC (NASDAQ), TAIWAN LIPOSOME COMPANY LTD SPON ADS EACH REP 2 ORD SHS (NASDAQ), PLURISTEM THERAPEUTICS INC (NASDAQ), PARATEK PHARMACEUTICALS INC (NASDAQ), VTV THERAPEUTICS INC (NASDAQ), IMV INC (NASDAQ), FIVE PRIME THERAPEUTICS (NASDAQ), JOUNCE THERAPEUTICS INC (NASDAQ), KEZAR LIFE SCIENCES INC (NASDAQ), STRONGBRIDGE BIOPHARMA PLC (NASDAQ), FENNEC PHARMACEUTICALS INC (NASDAQ), PIERIS PHARMACEUTICALS INC (NASDAQ), NEXT SCIENCE LTD (ASX), CELYAD ADS EACH REPR 1 ORD (NASDAQ), ERYTECH PHARMA SPON ADR EACH REPR 1 ORD (NASDAQ), DYADIC INTERNATIONAL INC (NASDAQ), MINERVA NEUROSCIENCES INC (NASDAQ), GALECTIN THERAPEUTICS INC (NASDAQ), ORGENESIS INC (NASDAQ), CABALETTA BIO INC (NASDAQ), ALDEYRA THERAPEUTICS (NASDAQ), CIDARA THERAPEUTICS INC (NASDAQ), ARBUTUS BIOPHARMA CORP (NASDAQ), BIOFRONTERA AG SPON ADS EACH REP TWO ORD SHS (NASDAQ), SIERRA ONCOLOGY INC (NASDAQ), SURFACE ONCOLOGY INC (NASDAQ), ENZO BIOCHEM INC (NYSE), TREVENA INC (NASDAQ), CONTRAFECT CORP (NASDAQ), X4 PHARMACEUTICALS INC (NASDAQ), SOLID BIOSCIENCES INC (NASDAQ), AXOVANT GENE THERAPIES LTD (NASDAQ), ELOXX PHARMACEUTICALS INC (NASDAQ), WINDTREE THERAPEUTICS INC (NASDAQ), CATALYST BIOSCIENCES INC (NASDAQ), AVALON GLOBOCARE CORP (NASDAQ), SAVARA INC (NASDAQ), NEUREN PHARMACEUTICALS LTD (ASX), GLYCOMIMETICS INC (NASDAQ), LA JOLLA PHARMACEUTICAL CO (NASDAQ), AVEO PHARMACEUTICALS INC (NASDAQ), APPLIED GENETIC TECHNOLOGIES CORP (NASDAQ), UNI-BIO GROUP (HKEx), CHAMPIONS ONCOLOGY INC (NASDAQ), LUMOS PHARMA INC (NASDAQ), CATABASIS PHARMACEUTICALS INC (NASDAQ), COHBAR INC (NASDAQ), RECRO PHARMA INC (NASDAQ), OUTLOOK THERAPEUTICS INC (NASDAQ), HARVARD BIOSCIENCE INC (NASDAQ), IMUGENE LIMITED (ASX), T2 BIOSYSTEMS INC (NASDAQ), LEAP THERAPEUTICS INC (NASDAQ), ONCOLYTICS BIOTECH INC (NASDAQ), ORGANOVO HLDGS INC (NASDAQ), AQUABOUNTY TECHNOLOGIES INC (NASDAQ), SESEN BIO INC (NASDAQ), BIOCRYST PHARMACEUTICALS INC (NASDAQ), OTONOMY INC (NASDAQ), MONOPAR THERAPEUTICS INC (NASDAQ), CAPRICOR THERAPEUTICS INC (NASDAQ), SYNLOGIC INC (NASDAQ), NABRIVA THERAPEUTICS PLC (NASDAQ), HEAT BIOLOGICS INC (NASDAQ), EDAP TMS S.A. SPON ADR EACH REPR 1 ORD SHARE (NASDAQ), GENOCEA BIOSCIENCES INC (NASDAQ), PROTEOSTASIS THERAPEUTICS INC (NASDAQ), ONCONOVA THERAPEUTICS INC (NASDAQ), RESTORBIO INC (NASDAQ), DIFFUSION PHARMACEUTICALS INC (NASDAQ), ALPINE IMMUNE SCIENCES INC (NASDAQ), STEALTH BIOTHERAPEUTICS CORP SPON ADS EACH REP 12 ORD SHS (NASDAQ), ASLAN PHARMACEUTICALS LIMITED ADS EACH REP 5 ORD SHS (NASDAQ), INVEX THERAPEUTICS LTD NPV (ASX), DIAMEDICA THERAPEUTICS INC (NASDAQ), IMMUTEP LTD (ASX), ANPAC BIO MEDICAL SCIENCE CO LTD SPON ADS EACH REPR 1 ORD SHS CLASS A (NASDAQ), INMUNE BIO INC (NASDAQ), VACCINEX INC (NASDAQ), EQUILLIUM INC (NASDAQ), IMMUTEP LTD SPON ADS EACH REP 10 ORD SHS (NASDAQ), IDERA PHARMACEUTICALS INC (NASDAQ), VASCULAR BIOGENICS LTD (NASDAQ), MIRAGEN THERAPEUTICS INC (NASDAQ), 9 METERS BIOPHARMA INC (NASDAQ), MICROBOT MEDICAL INC (NASDAQ), SEELOS THERAPEUTICS INC (NASDAQ), SOLIGENIX INC (NASDAQ), INFINITY PHARMACEUTICALS INC (NASDAQ), CYNATA THERAPEUTICS LTD (ASX), ANIXA BIOSCIENCES INC (NASDAQ), MERRIMACK PHARMACEUTICALS INC (NASDAQ), OPIANT PHARMACEUTICALS INC (NASDAQ), LARIMAR THERAPEUTICS INC (NASDAQ), BELLICUM PHARMACEUTICALS (NASDAQ), BIOTRON (ASX), ADVAXIS INC (NASDAQ), PULMATRIX INCORPORATED (NASDAQ), SUNESIS PHARMACEUTICALS INC (NASDAQ), ENTASIS THERAPEUTICS HLDGS INC (NASDAQ), FORWARD PHARMA AS SPON ADS EACH REP 14 ORD SHS (NASDAQ), SONNET BIOTHERAPEUTICS HLDGS INC (NASDAQ), ACORDA THERAPEUTICS INC (NASDAQ), ATYR PHARMA INC (NASDAQ), CT ENTERPRISE (HKEx), MEMPHASYS LTD (ASX), HTG MOLECULAR DIAGNOSTICS INC (NASDAQ), MEREO BIOPHARMA GROUP PLC SPON ADS EACH REP 5 ORD SHS (NASDAQ), BIOSINO BIO-TEC (HKEx), CURIS INC (NASDAQ), GENETIC TECHNOLOGIES (ASX), BIONANO GENOMICS INC (NASDAQ), HOLISTA COLLTECH LIMITED (ASX), KAZIA THERAPEUTICS LIMITED (ASX), BIOCARDIA INC (NASDAQ), TOCAGEN INC (NASDAQ), KAZIA THERAPEUTICS LIMITED SPON ADR EACH REP 10 ORD SHS (NASDAQ), EVOGENE LTD (NASDAQ), AETERNA ZENTARIS INC (NASDAQ), CCP TECHNOLOGIES LTD (ASX), ANTEOTECH LIMITED (ASX), ALIMERA SCIENCES INC (NASDAQ), ITERUM THERAPEUTICS PLC (NASDAQ), AIKIDO PHARMA INC (NASDAQ), CYCLACEL PHARMACEUTICALS INC (NASDAQ), SELLAS LIFE SCIENCES GROUP INC (NASDAQ), AZURRX BIOPHARMA INC (NASDAQ), VISTAGEN THERAPEUTICS INC (NASDAQ), SIENNA CANCER DIAGNOSTICS LTD (ASX), CLEVELAND BIOLABS INC (NASDAQ), Suntar Eco-City (SGX), BIO-PATH HOLDINGS INC (NASDAQ), APTEVO THERAPEUTICS INC (NASDAQ), GENETIC TECHNOLOGIES SPON ADS EA REP 600 ORD SHS(R/S) (NASDAQ), BIONOMICS LTD (ASX), UNUM THERAPEUTICS INC (NASDAQ), OCUGEN INC (NASDAQ), PRESCIENT THERAPEUTICS LIMITED (ASX), SENECA BIOPHARMA INC (NASDAQ), ACHIEVE LIFE SCIENCE INC (NASDAQ), REGENT PACIFIC (HKEx), REGENEUS LTD (ASX), ARCA BIOPHARMA INC (NASDAQ), ACTINOGEN MEDICAL LTD (ASX), CELLECTAR BIOSCIENCES INC (NASDAQ), PHIO PHARMACEUTICALS CORP (NASDAQ), ENDRA LIFE SCIENCES INC (NASDAQ), RHINOMED LIMITED (ASX), TRACON PHARMACEUTICALS INC (NASDAQ), ALTERITY THERAPEUTICS LIMITED (ASX), PATRYS LIMITED (ASX), PRECIPIO INC (NASDAQ), CELLECT BIOTECHNOLOGY LTD SPON ADS EACH REP 100 ORD SHS(POST SPLT) (NASDAQ), ALTERITY THERAPEUTICS LIMITED SPON ADS EA REPR 60 ORD SHS (NASDAQ), REXAHN PHARMACEUTICALS INC (NASDAQ), CONTANGO ASSET MANAGEMENT LIMITED (ASX), NEUROSCIENTIFIC BIOPHARMA LTD (ASX), ANCHIANO THERAPEUTICS LTD SPON ADS EACH REP 5 ORD SHS (NASDAQ), AVECHO BIOTECHNOLOGY LTD (ASX), ADALTA LTD (ASX), INVIVO THERAPEUTICS HOLDING CORP (NASDAQ), XTL BIOPHARMACEUTICALS LTD SPON ADS EACH REP 100 ORD SHS(POST SPLT) (NASDAQ), PLUS THERAPEUTICS INC (NASDAQ), SENESTECH INC (NASDAQ), MIDATECH PHARMA PLC SPON ADS EACH REP 5 ORD SHS(R/S) (NASDAQ), ANATARA LIFESCIENCES LTD (ASX), AMPLIA THERAPEUTICS LTD (ASX), XENETIC BIOSCIENCES INC (NASDAQ), HAO WEN HLDGS (HKEx), AUSTRALIAN PRIMARY HEMP LTD (ASX), CRYOSITE (ASX), LIVING CELL TECHNOLOGIES (ASX), AURIS MEDICAL HOLDING LTD (NASDAQ), LEAF RESOURCES LTD (ASX), THERAPIX BIOSCIENCES LTD SPON ADR EACH REP 40 ORD (POST SPLIT) (NASDAQ), NANOLLOSE LTD (ASX), FACTOR THERAPEUTICS LIMITED (ASX)
Notes:
  1. For companies, Market Cap is based on the trading currency of the company. Industry/Index Market Cap is the average market cap for that industry/index.
  2. Industry/Index PE is calculated using (Total Market Cap/Total Earnings) of all companies in the industry/index.
  3. Industry/Index Price/NAV is calculated using (Total Market Cap/Total Shareholders' Equity) of all companies in the industry/index.
  4. Industry/Index Dividend Yield is calculated using (Total Gross Dividend/Total Market Cap) of all companies in the industry/index.
  5. For Industry/Index calculation, data for foreign currency denominated companies will be converted to the main market currency using the latest exchange rate.
  6. Industry/Index/Peers data is updated daily.
  7. Peers are sorted by market capitalisation and only details for the top 10 will be shown.

Total Shareholder Return

PeriodDividend ReceivedCapital AppreciationTotal Shareholder Return
Short Term Return 5 Days --0.040
-6.62 %
10 Days --0.051
-8.30 %
20 Days -+0.045
+8.80 %
Medium Term Return 3 Months -+0.070
+14.35 %
6 Months --0.163
-22.50 %
1 Year --0.370
-39.75 %
Long Term Return 2 Years --0.020
-3.40 %
3 Years -+0.145
+35.01 %
5 Years -+0.098
+21.28 %
Annualised Return Annualised --
+3.93 %
Notes:
  1. Total Shareholder Return (TSR) combines share price appreciation and dividends paid to show the total return to the shareholder expressed as a percentage.
  2. Script dividends are ignored in this calculation.

Price Movements

1 Year Range 0.263 - 2.440 Change From 1 Year Low +0.297 % Change From 1 Year Low (%) +113.04
Change From 1 Year High -1.880 % Change From 1 Year High (%) -77.04
2 Years Range 0.263 - 14.580 Change From 2 Years Low +0.297 % Change From 2 Years Low (%) +113.04
Change From 2 Years High -14.020 % Change From 2 Years High (%) -96.16
5 Years Range 0.135 - 14.580 Change From 5 Years Low +0.425 % Change From 5 Years Low (%) +315.04
Change From 5 Years High -14.020 % Change From 5 Years High (%) -96.16
Notes:
  1. Price movements are based on adjusted historical data.

Company Background

India Globalization Capital, Inc. engages in the development and commercialization of cannabinoid based alternative therapies for indications such as Alzheimer's disease, Parkinson's disease, and pain. It operates through the Infrastructure Business and Plant & Cannabinoids Business segments. The Infrastructure Business segment involves the rental of heavy construction equipment, execution of construction contracts, and purchase and reseal of physical commodities used in infrastructure. The Plant & Cannabinoids Business segment comprises the production of plant and cannabinoid-based products, and therapies. The company was founded by Ram Mukunda on April 29, 2005 and is headquartered in Potomac, MD.

Historical Price Data

Date Open High Low Close Volume VWAP
03 Jun 2020 0.569 0.577 0.560 0.560 339,324 -
02 Jun 2020 0.582 0.600 0.551 0.560 725,725 -
01 Jun 2020 0.589 0.600 0.573 0.588 317,764 -
29 May 2020 0.600 0.600 0.571 0.585 418,681 -
28 May 2020 0.595 0.650 0.580 0.600 935,742 -
27 May 2020 0.600 0.609 0.570 0.605 834,432 -
26 May 2020 0.617 0.620 0.580 0.590 1,027,230 -
22 May 2020 0.609 0.660 0.560 0.615 3,322,255 -
21 May 2020 0.552 0.650 0.529 0.611 4,123,286 -
20 May 2020 0.525 0.545 0.520 0.543 458,682 -
19 May 2020 0.640 0.660 0.530 0.563 1,411,296 -
18 May 2020 0.525 0.590 0.509 0.590 2,736,016 -
15 May 2020 0.493 0.520 0.470 0.500 619,745 -
14 May 2020 0.480 0.495 0.450 0.490 366,641 -
13 May 2020 0.490 0.500 0.470 0.480 272,196 -
12 May 2020 0.503 0.520 0.490 0.494 421,291 -
11 May 2020 0.510 0.520 0.501 0.504 261,285 -
08 May 2020 0.506 0.530 0.502 0.512 345,209 -
07 May 2020 0.520 0.520 0.500 0.515 256,426 -
06 May 2020 0.510 0.520 0.490 0.520 222,946 -
05 May 2020 0.530 0.540 0.503 0.519 381,017 -
04 May 2020 0.516 0.561 0.502 0.541 630,317 -
Summary
Current 2 Weeks
(20 May 2020 to 03 Jun 2020)
0.525 0.660 0.520 0.560 12,503,121 -
Previous 2 Weeks
(06 May 2020 to 19 May 2020)
0.510 0.660 0.490 0.563 6,913,051 -
4 Weeks from
(07 Apr 2020 to 05 May 2020)
0.470 0.660 0.430 0.519 21,659,047 -
View All Historical Data

More Information Available

More information is available to our subscribers, including:

  • Market Moving News from Dow Jones Newswires
  • Consensus Estimates
  • Dividend/Distribution History
  • Financial Summary with Financial Period Comparison
  • Comprehensive Financial Ratios(ROA, ROE, Price/Revenue, Net Earnings Margin, Current Ratio, Debt to Equity Ratio etc)
  • Events Calendar for Results Announcements, Ex-Dates etc
  • Insider Buying and Selling Report

If you are an existing subscriber, please login. If not, read up on what you are missing out in our Help Centre and join us as a subscriber.

Disclaimer:

While reasonable efforts have been taken to ensure that the calculations performed by the features of this site are reliable, the features are provided on the basis that:-

  1. no liability is accepted for any errors or inaccuracies resulting from your use of these features;
  2. many of the data inputs (including share prices) are obtained from third party sources for which we assume no responsibility.
We use Cookies. By continuing to use this webite, you will be agreeing to our Privacy Policy, Terms and Conditions and Cookie Policy.